GBS (NASDAQ: GBS)
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-10 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.160 | -0.090 | 0.0700 | ||||
REV | 192.500K |
You can purchase shares of GBS (NASDAQ: GBS) through any online brokerage.
Other companies in GBS’s space includes: ENDRA Life Sciences (NASDAQ:NDRA), Tivic Health Systems (NASDAQ:TIVC), Motus GI Hldgs (NASDAQ:MOTS), NeuroOne Medical Tech (NASDAQ:NMTC) and Viveve Medical (NASDAQ:VIVE).
There is no analysis for GBS
The stock price for GBS (NASDAQ: GBS) is $0.5822 last updated May 20, 2022, 8:00 PM UTC.
There are no upcoming dividends for GBS.
GBS’s Q4 earnings are confirmed for Wednesday, August 10, 2022.
There is no upcoming split for GBS.
GBS is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.